Clinical Trial Update: The Intravitreal Autologous Platelet Concentrate Injection as an Adjunct of Vitrectomy for the Treatment of Refractory Macular Holes [NA]

View source ↗

Summary

This document reports an update on a clinical trial evaluating intravitreal autologous platelet concentrate as an adjunct to vitrectomy for refractory macular h…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Macular Hole

Drugs mentioned

• Autologous Platelet Concentrate (Autologous platelet concentrate)

Snippet

Sponsor: Samsung Medical Center | Conditions: Macular Hole With High Myopia (Spherical Equivalent ≤ -6.0 Diopters) or,, Large Size Macular Hole (Diameter > 600 Microns) or | NA | Status: UNKNOWN